tert-Butyl 3,7-diazabicyclo[3.3.1]nonane-3-carboxylate hydrochloride CAS:1523617-92-6
tert-Butyl 3,7-diazabicyclo[3.3.1]nonane-3-carboxylate hydrochloride offers multifaceted utility across various scientific disciplines. In organic synthesis, it serves as a pivotal building block for the construction of complex molecules, particularly those containing bicyclic and amino acid motifs. The tert-butyl group provides steric protection, while the carboxylate functionality enables facile derivatization, facilitating the synthesis of diverse molecular architectures with precision and efficiency. In medicinal chemistry, this compound demonstrates promising pharmacological activities, making it a compelling candidate for drug discovery endeavors targeting various diseases, including neurological disorders and infectious diseases. Researchers can harness its structural features to optimize drug properties such as potency, selectivity, and metabolic stability, thereby enhancing therapeutic efficacy and minimizing adverse effects. Furthermore, tert-Butyl 3,7-diazabicyclo[3.3.1]nonane-3-carboxylate hydrochloride finds application in chemical biology and drug development, serving as a versatile tool for the design and synthesis of bioactive molecules, enzyme inhibitors, and drug conjugates. Its unique reactivity and pharmacological properties make it invaluable for probing biological pathways, elucidating drug mechanisms of action, and developing innovative therapeutic strategies tailored to specific molecular targets. In summary, tert-Butyl 3,7-diazabicyclo[3.3.1]nonane-3-carboxylate hydrochloride emerges as a fundamental and indispensable compound for researchers across various scientific disciplines, offering extensive opportunities for innovation and discovery in organic synthesis, medicinal chemistry, and chemical biology.
Composition | C12H23ClN2O2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 1523617-92-6 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |